FSA compares the Fidelity Asian Smaller Companies fund and the T. Rowe Price Asian Opportunities Equity fund for this week’s head-to-head.
Tag: Darius McDermott
Is it time to re-consider thriving China funds amid their rally?
China funds could be back on the menu after roaring back with some of the highest returns of 2024.
Global equities: BNY Investments versus Morgan Stanley
As part of FSA’s head-to-head series, we compare the BNY Mellon Global Leaders fund and the Morgan Stanley Global Brands fund.
FundCalibre: Can financials surprise again in 2025?
Financials delivered the best sector returns of last year, but can it repeat the trick in 2025, asks Darius McDermott.
Asia ex-Japan equities: Invesco versus JOHCM
As part of FSA’s head-to-head series, we compare the Invesco Asian fund and the JOHCM Asia ex‐Japan fund.
Japan equities: M&G versus MFS Meridian
As part of FSA’s head-to-head series, we compare the M&G Japan fund and the MFS Meridian Japan Equity fund.
Healthcare: Fidelity versus Polar Capital
As part of FSA’s head-to-head series, we compare the Fidelity Sustainable Healthcare fund and the Polar Capital Biotechnology fund.
M&G fixed income head Jim Leaviss announces departure
Jim Leaviss is stepping down after a 27-year career with M&G Investments to pursue a masters in the history of art.
Emerging market equities: Federated Hermes versus Invesco
As part of FSA’s head-to-head series, we compare the Federated Hermes Global Emerging Markets SMID Equity fund and the Invesco Emerging Markets ex-China fund.
M&G versus Invesco: Equity Income
As part of FSA’s Head-to-Head series, this week we compare the M&G Global Dividend fund and the Invesco Global Equity Income fund.
